TG Therapeutics, Inc. (TGTX)
39.24
-0.52
(-1.31%)
USD |
NASDAQ |
May 21, 16:00
39.22
-0.02
(-0.05%)
After-Hours: 19:59
TG Therapeutics Research and Development Expense (TTM) : 162.25M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Krystal Biotech, Inc. | 54.64M |
| Precision BioSciences, Inc. | 52.46M |
| AnaptysBio, Inc. | 128.24M |
| Catalyst Pharmaceuticals, Inc. | 11.48M |
| Geron Corp. | 73.59M |